Home » Topics » Regulatory

Regulatory
RSS

Novartis files NDA for extended-release formulation of fluvastatin

Dec. 16, 1999

NIH-sponsored study fails to confirm efficacy of secretin in autism

Dec. 14, 1999

Mallinckrodt's MRI contrast agent approved for marketing in U.S.

Dec. 13, 1999

Dusa receives first approval of Levulan PDT for treatment of actinic keratoses

Dec. 10, 1999

Zoloft receives FDA approval for posttraumatic stress disorder

Dec. 10, 1999

Novartis reports setbacks and advances in the development of new chelating agents

Dec. 8, 1999

FDA advisory panel will review MS indication for Novantrone in early 2000

Dec. 8, 1999

Nasonex Nasal Spray approved for new pediatric indication in U.S.

Dec. 3, 1999

FDA approves new epilepsy treatment

Dec. 2, 1999

V1A/AT1 receptor antagonist combinations for cardiovascular disorders

Dec. 2, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...